Amarin | Spese Operative



Operating Expenses Cambiamento Data
AbbVie USD 9.61B 6.98B 2025-03
Alnylam Pharmaceuticals USD 698.32M 120.5M 2024-12
Amarin USD 67.47M 549K 2024-09
AstraZeneca USD 9.91B 2.94B 2025-03
DBV Technologies USD 31.4M 3.6M 2024-09
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Novartis USD 11.28B 1.73B 2024-12



Amarin Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.